BioCelerate is a subsidiary of TransCelerate BioPharma, and draws upon separate funding and support. In order to participate in BioCelerate it is necessary to be a Member Company of TransCelerate BioPharma, Inc. TransCelerate membership is available to biopharmaceutical research and development organizations who engage in innovative discovery, development and manufacturing of new drugs. Information about membership and a membership application is available on the TransCelerate website. BioCelerate initiatives are approved by a Governing Council comprised of representatives from participating BioCelerate Companies.
Janice Chang, CEO of BioCelerate
Janice Chang is the Chief Executive Officer at TransCelerate and a longtime champion of the potential of clinical research to accelerate answers for patients.
Since her appointment as CEO in 2023, Janice has worked closely with TransCelerate’s board of directors to identify and shape a new aspiration for the organization focused on driving the convergence of clinical research and clinical care. Under her leadership, TransCelerate has also extended its horizon for collaboration beyond the world of global biopharma companies to include other stakeholders across the R&D ecosystem.
Janice’s ongoing responsibilities include defining organizational priorities and overseeing the delivery of active initiatives. With her trademark high energy, commitment and courage, Janice also leads TransCelerate’s engagement with global health authorities, governmental agencies, academic research institutions, and industry consortia.
She has been involved with TransCelerate since its inception in 2012 and holds a dual degree from the University of Pennsylvania and The Wharton School.
